[HTML][HTML] Endothelin receptor antagonists: status quo and future perspectives for targeted therapy
The endothelin axis, recognized for its vasoconstrictive action, plays a central role in the
pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …
pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …
Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
FC Enevoldsen, J Sahana… - Journal of clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
The endothelin axis, recognized for its vasoconstrictive action, plays a central role in the
pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …
pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …
Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy.
FC Enevoldsen, J Sahana, M Wehland… - Journal of Clinical …, 2020 - europepmc.org
The endothelin axis, recognized for its vasoconstrictive action, plays a central role in the
pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …
pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …
Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy.
FC Enevoldsen, J Sahana, M Wehland… - Journal of Clinical …, 2020 - search.ebscohost.com
The endothelin axis, recognized for its vasoconstrictive action, plays a central role in the
pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …
pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …
Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
FC Enevoldsen, J Sahana, M Wehland… - Journal of Clinical …, 2020 - search.proquest.com
The endothelin axis, recognized for its vasoconstrictive action, plays a central role in the
pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …
pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …
Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
FC Enevoldsen, J Sahana, M Wehland… - Journal of Clinical …, 2020 - cir.nii.ac.jp
抄録< jats: p> The endothelin axis, recognized for its vasoconstrictive action, plays a central
role in the pathology of pulmonary arterial hypertension (PAH). Treatment with approved …
role in the pathology of pulmonary arterial hypertension (PAH). Treatment with approved …
[PDF][PDF] Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
FC Enevoldsen, J Sahana, M Wehland… - J. Clin …, 2020 - pdfs.semanticscholar.org
The endothelin axis, recognized for its vasoconstrictive action, plays a central role in the
pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …
pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …
[引用][C] 1. Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
FC Enevoldsen - spandidos-publications.com
[HTML][HTML] Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
FC Enevoldsen, J Sahana, M Wehland… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
The endothelin axis, recognized for its vasoconstrictive action, plays a central role in the
pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …
pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …
[PDF][PDF] Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
FC Enevoldsen, J Sahana, M Wehland, D Grimm… - J. Clin …, 2020 - opendata.uni-halle.de
The endothelin axis, recognized for its vasoconstrictive action, plays a central role in the
pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …
pathology of pulmonary arterial hypertension (PAH). Treatment with approved endothelin …